KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patientsGeorg Schäfer(Innsbruck Medical University), Isabel Heidegger(Innsbruck Medical University)Translational Andrology and UrologyJune 16, 202110.21037/tau-20-1084Cited by 9SaveCiteExport RISWatch citationsRelated PapersComprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer|Molecular Cancer|2022|177Diverse Functions of IGF/Insulin Signaling in Malignant and Noncancerous Prostate Cells: Proliferation in Cancer Cells and Differentiation in Noncancerous Cells|Endocrinology|2012|49